These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27891664)

  • 1. Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria.
    Nieminen O; Korppi M; Helminen M
    Acta Paediatr; 2017 Feb; 106(2):327-333. PubMed ID: 27891664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
    Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
    Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
    Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
    J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and characteristics of urinary tract infections in children and adolescents.
    Hanna-Wakim RH; Ghanem ST; El Helou MW; Khafaja SA; Shaker RA; Hassan SA; Saad RK; Hedari CP; Khinkarly RW; Hajar FM; Bakhash M; El Karah D; Akel IS; Rajab MA; Khoury M; Dbaibo GS
    Front Cell Infect Microbiol; 2015; 5():45. PubMed ID: 26075187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
    Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
    Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
    Esteve-Palau E; Solande G; Sánchez F; Sorlí L; Montero M; Güerri R; Villar J; Grau S; Horcajada JP
    J Infect; 2015 Dec; 71(6):667-74. PubMed ID: 26380898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection.
    MacVane SH; Tuttle LO; Nicolau DP
    J Hosp Med; 2014 Apr; 9(4):232-8. PubMed ID: 24464783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
    Briongos-Figuero LS; Gómez-Traveso T; Bachiller-Luque P; Domínguez-Gil González M; Gómez-Nieto A; Palacios-Martín T; González-Sagrado M; Dueñas-Laita A; Pérez-Castrillón JL
    Int J Clin Pract; 2012 Sep; 66(9):891-6. PubMed ID: 22897466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
    Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
    Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
    Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG
    Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study.
    Amin O; Prestel C; Gonzalez MD; Lyon T; Shane A; Jaggi P; Tippett A; Yildirim I
    Pediatr Infect Dis J; 2020 Mar; 39(3):211-216. PubMed ID: 32032306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum beta lactamase (ESBL) producing bacteria urinary tract infections and complex pediatric urology.
    Wragg R; Harris A; Patel M; Robb A; Chandran H; McCarthy L
    J Pediatr Surg; 2017 Feb; 52(2):286-288. PubMed ID: 27894763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
    Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
    Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
    Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E
    J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia.
    Al-Otaibi FE; Bukhari EE
    Saudi Med J; 2013 Feb; 34(2):171-6. PubMed ID: 23396464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
    PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary tract infections owing to ESBL-producing bacteria: microorganisms change--clinical pattern does not.
    Özçakar ZB; Yalçınkaya F; Kavaz A; Kadıoğlu G; Elhan AH; Aysev D; Güriz H; Ekim M
    Acta Paediatr; 2011 Aug; 100(8):e61-4. PubMed ID: 21392102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.